Lymphotropic therapy in the treatment of tuberculosis
One of the current issues in tuberculosis treatment is the intolerance to anti-tuberculosis drugs, which drives the search for the most effective method of delivering medications to the site of inflammation. A review of literature sources from the databases RSCI, Google Scholar, PubMed, and Scopus, covering the period from 1984 to 2020, was conducted, focusing on the use of endolymphatic therapy in patients with tuberculosis of various localizations. The analysis showed that the effectiveness of endolymphatic administration of anti-tuberculosis agents improves treatment outcomes for patients with progressive tuberculosis.
Authors
- S. S. Sаdovnikovа (ORCID: https://orcid.org/0000-0002-6589-2834)
- М. А. Багиров (ORCID: https://orcid.org/0000-0001-9788-1024)
- R. V. Tarasov (ORCID: https://orcid.org/0000-0001-9498-1142)
- A. M. Tikhonov
- E. V. Krаsnikovа (ORCID: https://orcid.org/0000-0002-5879-7062)
- Alexandra M. Zakharova
Institutions
- Samara Medical Institute Reaviz (RU)
- Central Research Institute (IN)
- Ministry of Health of the Russian Federation (RU)
- Central Scientific Research Institute of Tuberculosis Russian Academy of Medical Sciences (RU)
Publication Details
- Journal
- Clinical Medicine (Russian Journal)
- Published
- 2025-01-09
- DOI
- https://doi.org/10.30629/0023-2149-2024-102-8-593-601
- Primary Topic
- Hematological disorders and diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00